v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT (Unaudited) - USD ($)
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance – February 28, 2025 at Nov. 30, 2024 [1] $ 290 $ 24,710 $ (10,166) $ 14,834
Beginning balance shares at Nov. 30, 2024 2,898,000      
Net loss (31,255) (31,255)
Balance – May 31, 2025 at Feb. 28, 2025 [1] $ 290 24,710 (41,421) (16,421)
Ending balance shares at Feb. 28, 2025 2,898,000      
Issuance of Private Placement Units $ 23 2,318,977 2,319,000
Issuance of Private Placement Units, shares 231,900      
Issuance of Public Rights net of issuance costs 1,804,080 1,804,080
Remeasurement of carrying value to redemption value (6,858,776) (6,858,776)
Accretion of additional paid-in capital to accumulated deficit 2,711,009 (2,711,009)
Net loss (27,147) (27,147)
Balance – May 31, 2025 at May. 31, 2025 $ 313 (2,779,577) (2,779,264)
Ending balance shares at May. 31, 2025 3,129,900      
Balance – February 28, 2025 at Nov. 30, 2025 $ 313 (3,920,003) (3,919,690)
Beginning balance shares at Nov. 30, 2025 3,129,900      
Remeasurement of carrying value to redemption value (759,908) (759,908)
Net loss 529,085 529,085
Balance – May 31, 2025 at Feb. 28, 2026 $ 313 (4,150,826) (4,150,513)
Ending balance shares at Feb. 28, 2026 3,129,900      
Remeasurement of carrying value to redemption value (770,237) (770,237)
Net loss 573,672 573,672
Balance – May 31, 2025 at May. 31, 2026 $ 313 $ (4,347,391) $ (4,347,078)
Ending balance shares at May. 31, 2026 3,129,900      
[1] Ordinary shares have been retroactively restated to reflect two amendments to the Subscription Agreement, which allowed the Sponsor to increase the purchase of ordinary shares initially from 1,725,000 to 2,415,000, then to 2,898,000 shares for $25,000, including an aggregate of up to 378,000 ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5).